Hanmi Pharm’s combination drug ‘Gugu Tams’ enters Samsung Medical Center
‘Gugu Tams,’ a Hanmi Pharm’s benign prostatic hyperplasia and erectile dysfunction treatment, entered Samsung Medical Center.
According to the industry concerned, Hanmi Pharm’s Gugu Tams, Novartis’ Fytarex, Hanlim Pharm’s Lotepro Ophthalmic Suspension and Jinyang Pharm’s Kamistad-N Gel entered S...
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.